IVF Success Rates: What Really Determines Your Chance of Pregnancy?

One of the first questions patients ask before IVF is:

“What is my chance of success?”

It sounds like a question that should have a simple percentage as an answer.

It does not.

IVF success rates are influenced by many interacting factors, and a percentage reported by a clinic, national registry or online calculator describes a particular population—not necessarily the individual patient sitting in front of the fertility specialist.

Female age is extremely important, but it is only the beginning.

The source of the eggs, ovarian response, sperm quality, embryo development, uterine environment, previous fertility history and even what is meant by “success” can substantially change the number.

Understanding these factors makes IVF statistics far more useful.

First: What Does “IVF Success” Mean?

Before comparing percentages, ask what outcome is actually being reported.

IVF success can refer to:

• Positive pregnancy test
• Clinical pregnancy
• Ongoing pregnancy
• Implantation
• Live birth
• Live birth per embryo transfer
• Live birth per egg retrieval
• Cumulative live birth after several transfers

These are not interchangeable.

A pregnancy rate will normally be higher than a live-birth rate because not every pregnancy progresses to delivery.

For most patients, live birth is ultimately the most meaningful endpoint.

Cumulative success can also provide a different perspective from success after a single embryo transfer because one egg retrieval may produce several embryos that can be transferred separately.

Age Is One of the Strongest Factors

When a woman is using her own eggs, age is one of the most powerful predictors of IVF outcome.

The reason is not simply that fewer eggs remain as women become older.

The proportion of oocytes with chromosome abnormalities also increases with reproductive age.

This is why two women with similar AMH levels but different ages can have very different probabilities of producing a chromosomally competent embryo.

The difference becomes increasingly important after 35 and particularly after 40.

But age should still be interpreted precisely.

A woman who has just turned 40 should not automatically be placed in the same biological category as a woman of 44.

Individual assessment matters.

Does AMH Predict IVF Success?

AMH is extremely useful—but frequently misunderstood.

It primarily helps predict ovarian response and the likely number of eggs obtained during stimulation.

A woman with higher AMH may produce more oocytes, while a woman with very low AMH may produce only a few.

However, AMH is only weakly associated with qualitative outcomes such as egg quality, clinical pregnancy and live birth independently of age.

ASRM specifically emphasizes this distinction.

So instead of asking:

“Is my AMH high enough to become pregnant?”

a more useful question is:

“What does my AMH suggest about how my ovaries may respond to IVF?”

The Number of Eggs Matters—but It Is Not the Final Goal

IVF involves a sequence of biological steps.

Not every follicle produces an egg.

Not every retrieved egg is mature.

Not every mature egg fertilizes.

Not every fertilized egg becomes a blastocyst.

And not every blastocyst has the biological potential to become a baby.

The pathway can be thought of as:

follicles → retrieved eggs → mature eggs → fertilization → embryos → blastocysts → implantation → live birth

This is why obtaining more eggs can create more opportunities, particularly when age-related embryo aneuploidy becomes more common.

But the objective is not simply a high egg count.

The objective is obtaining an embryo capable of producing a healthy pregnancy.

Embryo Development Tells Us Something New

Once IVF has begun, the embryos themselves provide additional information.

How many eggs fertilized?

How many embryos continued dividing?

How many reached the blastocyst stage?

Were embryos suitable for transfer or freezing?

If genetic testing was performed, were euploid embryos obtained?

These observations can sometimes become more informative than the original ovarian-reserve tests.

This is particularly relevant after previous unsuccessful IVF.

Rather than simply repeating the same protocol, the fertility team can examine where in the process the previous cycle lost reproductive potential.

That can help determine what should change next.

How Important Is Sperm Quality?

Very.

The sperm contributes half of the embryo’s nuclear DNA.

Conventional semen analysis evaluates concentration, motility and morphology, while selected patients may benefit from additional investigation such as sperm DNA fragmentation testing.

Male factors may influence:

• Fertilization
• Embryo development
• Embryo genetic integrity
• Pregnancy outcome

This is why IVF success should never be approached exclusively as a female issue.

When embryo development is unexpectedly poor or repeated treatment fails, both partners deserve appropriate reassessment.

Does the Endometrium Affect IVF Success?

A competent embryo also needs an appropriate uterine environment.

Factors that may influence implantation include uterine abnormalities, endometrial pathology, hydrosalpinx and other selected maternal conditions.

Endometrial thickness can provide useful information, but it should not be treated as a rigid pass/fail number.

And after one unsuccessful embryo transfer, it is rarely useful to assume immediately that there is an implantation disorder.

ESHRE recommends interpreting repeated implantation failure according to the individual patient’s cumulative expected probability of implantation, rather than diagnosing it simply after a fixed number of failed transfers.

In other words, sometimes an unsuccessful transfer represents a biological probability—not evidence that something is fundamentally wrong.

What If a Good Embryo Does Not Implant?

This is one of the most frustrating IVF experiences.

A morphologically good embryo is not necessarily a chromosomally normal embryo, and even a euploid embryo does not guarantee implantation.

When repeated transfers fail, investigation should become increasingly individualized.

Depending on the clinical history, attention may turn toward:

• Uterine anatomy
• Endometrial factors
• Hydrosalpinx
• Selected endocrine conditions
• Embryo factors
• Male factors
• Previous transfer characteristics

The key is to investigate plausible causes, rather than automatically ordering every available fertility test after an unsuccessful cycle.

Own Eggs and Donor Eggs Produce Very Different Statistics

When reading IVF success rates, always check whether the data refer to:

the patient’s own eggs or donor eggs.

With own-egg IVF, female age strongly influences the probability of obtaining a competent embryo.

With donor eggs, the biological age of the egg donor becomes highly important for embryo competence.

This is why donor-egg success rates can remain comparatively strong even when the recipient is in her late 40s, perimenopause, menopause or selected postmenopausal circumstances.

Recipient age still matters medically, particularly for pregnancy-related health risks, but it does not age the donated oocyte.

Comparing donor-egg statistics directly with own-egg IVF statistics can therefore be misleading.

What About IVF During Perimenopause?

Perimenopause does not necessarily mean that ovarian activity has stopped.

Women may still develop follicles and occasionally ovulate.

The difficulty is that both the number of available follicles and the probability of obtaining a chromosomally competent oocyte are generally lower at this stage.

A fertility assessment should therefore determine whether useful ovarian activity remains before deciding between own-egg IVF and alternative strategies.

This is different from established menopause and postmenopause, when useful spontaneous follicular activity becomes much less likely.

Can Regenerative Fertility Change the IVF Strategy?

For selected women with diminished ovarian reserve, poor ovarian response, premature ovarian insufficiency or declining ovarian activity, regenerative approaches may be considered before another IVF attempt.

At Chania Fertility Unit, these can include ovarian PRP, enriched PRP, stem-cell-based approaches and exosome therapy.

The relevant outcome is not simply whether a laboratory marker changes.

The more meaningful questions are:

Did follicular activity change?

Did ovarian response improve?

Could mature oocytes be obtained?

Did this create an additional reproductive opportunity?

This is why regenerative treatment should be evaluated within the broader IVF pathway rather than by AMH changes alone.

Why Clinic Success Rates Need Context

A fertility clinic reporting a high success rate may treat a very different patient population from another clinic.

One clinic may perform many donor-egg cycles.

Another may treat large numbers of women over 40 using their own eggs.

Another may accept particularly complex cases after repeated IVF failure elsewhere.

Their headline percentages cannot be compared fairly without understanding the patients behind them.

The CDC similarly warns that average ART success rates may not reflect an individual patient’s actual probability because outcomes vary according to factors such as age, infertility diagnosis, previous pregnancy and ART procedures used.

This is why personalized prognosis is more useful than choosing a fertility centre according to one headline percentage.

One IVF Cycle Does Not Always Tell the Whole Story

Patients understandably focus on the result of the next embryo transfer.

But fertility treatment can also be considered cumulatively.

One ovarian stimulation may produce several blastocysts.

One transfer may fail while another embryo from the same retrieval subsequently results in pregnancy.

Similarly, some patients undergo more than one retrieval to obtain or accumulate embryos.

The question can therefore change from:

“What is my chance in this transfer?”

to:

“What is my cumulative chance of achieving a live birth from the treatment strategy we are planning?”

That is often a much more useful conversation.

Frequently Asked Questions

What is a good IVF success rate?

There is no meaningful universal percentage. Success depends on the outcome being measured, female age, egg source, diagnosis, embryo characteristics and patient population.

What is the biggest factor affecting IVF success?

For women using their own eggs, female age is one of the strongest predictors because it is closely related to oocyte and embryo chromosome competence.

Does high AMH mean IVF will work?

No. Higher AMH generally predicts a stronger ovarian response and potentially more eggs, but it does not guarantee pregnancy or live birth.

Can IVF work with low AMH?

Yes. Low AMH usually predicts fewer available eggs rather than proving that IVF cannot result in pregnancy. ASRM states that even extremely low AMH should not be used by itself to refuse IVF treatment.

Does a failed embryo transfer mean I have implantation failure?

Not necessarily. Implantation is probabilistic, and ESHRE recommends considering the individual’s expected cumulative chance before deciding that repeated failure warrants additional investigation.

Are donor-egg IVF success rates affected by the recipient’s age?

The donor’s age is particularly important for the genetic competence of the oocyte. Recipient age remains relevant to maternal health and pregnancy risks but should not be interpreted in the same way as age in own-egg IVF.

IVF Success Rates: Ask for Your Probability, Not Just a Percentage

IVF success rates are useful when they are interpreted correctly.

They become misleading when one percentage is applied to everyone.

A meaningful IVF prognosis brings together:

age + egg source + ovarian response + sperm quality + embryo development + uterine factors + reproductive history + treatment strategy.

At Chania Fertility Unit, this individualized approach is particularly important because patients can present at very different stages of reproductive life—from younger couples beginning their first IVF cycle to women with diminished ovarian reserve, patients over 40, women in perimenopause, international patients seeking donor eggs and patients exploring regenerative fertility options.

The Unit currently provides IVF, ICSI, egg donation and regenerative fertility treatments and emphasizes personalized care under the scientific direction of Dr Matthaios Fraidakis, backed by more than 30 years of IVF experience.

So when considering IVF, perhaps the most useful question is not:

“What is the IVF success rate?”

It is:

“What factors determine my individual chance—and what can we realistically optimize before my next attempt?”